Taylor Morrison Home Statistics
Total Valuation
TMHC has a market cap or net worth of $6.15 billion. The enterprise value is $7.87 billion.
| Market Cap | 6.15B |
| Enterprise Value | 7.87B |
Important Dates
The last earnings date was Wednesday, February 12, 2025, before market open.
| Earnings Date | Feb 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TMHC has 101.74 million shares outstanding. The number of shares has decreased by -3.00% in one year.
| Current Share Class | 101.74M |
| Shares Outstanding | 101.74M |
| Shares Change (YoY) | -3.00% |
| Shares Change (QoQ) | -0.82% |
| Owned by Insiders (%) | 2.64% |
| Owned by Institutions (%) | 98.98% |
| Float | 99.01M |
Valuation Ratios
The trailing PE ratio is 7.31 and the forward PE ratio is 6.73.
| PE Ratio | 7.31 |
| Forward PE | 6.73 |
| PS Ratio | 0.78 |
| Forward PS | 0.73 |
| PB Ratio | 1.05 |
| P/TBV Ratio | 1.18 |
| P/FCF Ratio | 35.42 |
| P/OCF Ratio | 29.29 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.12, with an EV/FCF ratio of 45.27.
| EV / Earnings | 8.91 |
| EV / Sales | 0.96 |
| EV / EBITDA | 6.12 |
| EV / EBIT | 6.33 |
| EV / FCF | 45.27 |
Financial Position
The company has a current ratio of 6.51, with a Debt / Equity ratio of 0.37.
| Current Ratio | 6.51 |
| Quick Ratio | 0.59 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 1.69 |
| Debt / FCF | 12.66 |
| Interest Coverage | 93.37 |
Financial Efficiency
Return on equity (ROE) is 15.82% and return on invested capital (ROIC) is 10.02%.
| Return on Equity (ROE) | 15.82% |
| Return on Assets (ROA) | 8.65% |
| Return on Invested Capital (ROIC) | 10.02% |
| Return on Capital Employed (ROCE) | 15.33% |
| Revenue Per Employee | $2.92M |
| Profits Per Employee | $315,468 |
| Employee Count | 2,800 |
| Asset Turnover | 0.91 |
| Inventory Turnover | 1.03 |
Taxes
In the past 12 months, TMHC has paid $269.55 million in taxes.
| Income Tax | 269.55M |
| Effective Tax Rate | 23.31% |
Stock Price Statistics
The stock price has increased by +4.84% in the last 52 weeks. The beta is 2.06, so TMHC's price volatility has been higher than the market average.
| Beta (5Y) | 2.06 |
| 52-Week Price Change | +4.84% |
| 50-Day Moving Average | 62.80 |
| 200-Day Moving Average | 64.10 |
| Relative Strength Index (RSI) | 41.85 |
| Average Volume (20 Days) | 1,164,189 |
Short Selling Information
The latest short interest is 2.84 million, so 2.79% of the outstanding shares have been sold short.
| Short Interest | 2.84M |
| Short Previous Month | 2.18M |
| Short % of Shares Out | 2.79% |
| Short % of Float | 2.86% |
| Short Ratio (days to cover) | 2.66 |
Income Statement
In the last 12 months, TMHC had revenue of $8.17 billion and earned $883.31 million in profits. Earnings per share was $8.27.
| Revenue | 8.17B |
| Gross Profit | 2.01B |
| Operating Income | 1.24B |
| Pretax Income | 968.08M |
| Net Income | 883.31M |
| EBITDA | 1.28B |
| EBIT | 1.24B |
| Earnings Per Share (EPS) | $8.27 |
Balance Sheet
The company has $487.15 million in cash and $2.20 billion in debt, giving a net cash position of -$1.71 billion or -$16.83 per share.
| Cash & Cash Equivalents | 487.15M |
| Total Debt | 2.20B |
| Net Cash | -1.71B |
| Net Cash Per Share | -$16.83 |
| Equity (Book Value) | 5.88B |
| Book Value Per Share | 57.38 |
| Working Capital | 6.54B |
Cash Flow
In the last 12 months, operating cash flow was $210.08 million and capital expenditures -$36.33 million, giving a free cash flow of $173.75 million.
| Operating Cash Flow | 210.08M |
| Capital Expenditures | -36.33M |
| Free Cash Flow | 173.75M |
| FCF Per Share | $1.71 |
Margins
Gross margin is 24.65%, with operating and profit margins of 15.22% and 10.81%.
| Gross Margin | 24.65% |
| Operating Margin | 15.22% |
| Pretax Margin | 14.15% |
| Profit Margin | 10.81% |
| EBITDA Margin | 15.73% |
| EBIT Margin | 15.22% |
| FCF Margin | 2.13% |
Dividends & Yields
TMHC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.00% |
| Shareholder Yield | 3.00% |
| Earnings Yield | 14.35% |
| FCF Yield | 2.82% |
Analyst Forecast
The average price target for TMHC is $83.50, which is 38.04% higher than the current price. The consensus rating is "Buy".
| Price Target | $83.50 |
| Price Target Difference | 38.04% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMHC has an Altman Z-Score of 3.96 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.96 |
| Piotroski F-Score | 6 |